Preventive Care
From the Journals
False-positive mammography results and risk for cancer death
The analysis provides clues about which patients with false-positive mammography results will go on to develop breast cancer and “can be used to...
From the Journals
People with diabetes have a higher risk of colon cancer: Study
The authors concluded that increased referrals for colonoscopies among people with diabetes, particularly among those newly diagnosed, could...
Latest News
Medicare preventive visits up over 20 years, clinicians say this is a good thing
These visits give clinicians and patients more valuable time together.
Conference Coverage
Better postpartum BP control with self-monitoring: POP-HT
“This trial identifies a potential need for a paradigm shift in the way women affected by hypertensive pregnancy are managed postnatally,” said Dr...
Conference Coverage
Apixaban cuts stroke but ups bleeding in subclinical AFib: ARTESIA
The big question is whether the reduction in stroke with anticoagulation outweighs the increase in major bleeding.
Applied Evidence
Getting PrEP to the patients who need it
A fraction of those eligible for PrEP to prevent HIV infection receive a prescription. Newer drug regimens and updated recommendations can help...
Commentary
The future of medicine is RNA
A single injection that can suppress protein synthesis for an entire year? If it really works, it changes the game.
Guidance for Practicing Primary Care
Can vitamin and mineral supplementation prevent cancer or cardiovascular disease?
Listen to your patients about vitamin and mineral supplements, answer their questions, and tell them the facts.
Conference Coverage
Pregnancy in rheumatic disease quadruples risk of cardiovascular events
Pregnant patients with lupus and concomitant APS had an 18-fold higher risk for a cardiovascular event during and up to 6 weeks postpartum than...
Conference Coverage
Pregnancies with low anti-SSA/Ro autoantibody levels: Forgo fetal heart rhythm monitoring?
The ongoing prospective multicenter trial is the largest of its kind.
Conference Coverage
Semaglutide ‘a new pathway’ to CVD risk reduction: SELECT
The SELECT trial was “a turning point in the treatment of obesity and a call to action.”